Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Substantial Pre-Launch Inventory Lilly has already amassed nearly $550 million in pre-launch inventory of orforglipron, a move that is both early and sizable compared to industry norms
Giving confidence and peace of mind to our customers and community is important, so were sharing the standards we adhere to at Hims & Hers to ensure the safety and quality of our offerings
With anticipation of aleniglipron being a strong contender in the still-emergent GLP-1 pill space, investors who take a chance on GPCR shares may be rewarded with a bump when new results do become available, although this is, of course, a risk
Barring any unforeseen complications, orforglipron is on track to be the next big new GLP-1 approval
US$ 25.42
US$ 28.93
US$ 24.36
US$ 26.20
US$ 20.59
